Personensuche
Personensuche
Es wurde 1 Person gefunden.
Anschrift
Hufelandstraße 55
45147 Essen
45147 Essen
Telefon
Telefax
E-Mail
Webseite
Sprechzeiten
ab 17 Uhr
Funktionen
-
Funktionsoberarzt/-ärztin, Klinik für Neurologie
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
Keine vergangenen Veranstaltungen.
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccineIn: Nature Communications Jg. 15 (2024) Nr. 1, 6870Online Volltext: dx.doi.org/ (Open Access)
-
KDM5B predicts temozolomide-resistant subclones in glioblastomaIn: iScience Jg. 27 (2024) Nr. 1, 108596Online Volltext: dx.doi.org/ (Open Access)
-
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trialIn: Nature Communications Jg. 15 (2024) Nr. 1, 4210Online Volltext: dx.doi.org/ (Open Access)
-
Predictors and surgical outcome of hemorrhagic metastatic brain malignanciesIn: Journal of Neuro-Oncology Jg. 169 (2024) Nr. 1, S. 165 - 173Online Volltext: dx.doi.org/ (Open Access)
-
The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma : A Comparison of Tissue, ⁶⁸Ga-FAPI-46 PET Data, and Survival DataIn: Journal of Nuclear Medicine (JNM) Jg. 65 (2024) Nr. 8, S. 1217 - 1223Online Volltext: dx.doi.org/
-
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaIn: Clinical Cancer Research Jg. 29 (2023) Nr. 2, S. 488 - 500Online Volltext: dx.doi.org/ (Open Access)
-
Are we providing best available care to newly diagnosed glioblastoma patients? : Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022In: Neuro-Oncology Advances Jg. 5 (2023) Nr. 1, vdad105Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRIIn: Nuclear Medicine Communications Jg. 44 (2023) Nr. 12, S. 1106 - 1113Online Volltext: dx.doi.org/
-
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastomaIn: Neuro-Oncology Advances Jg. 5 (2023) Nr. 1, vdad090Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Precision neuro-oncology : A pilot analysis of personalized treatment in recurrent gliomaIn: Journal of Cancer Research and Clinical Oncology Jg. 149 (2023) Nr. 7, S. 3513 - 3526Online Volltext: dx.doi.org/ (Open Access)
-
Telemedicine in Neuro-Oncology : An Evaluation of Remote Consultations during the COVID-19 PandemicIn: Cancers Jg. 15 (2023) Nr. 16, 4054Online Volltext: dx.doi.org/ (Open Access)
-
Gender disparity regarding work-life balance satisfaction among German neuro-oncologists : A YoungNOA surveyIn: Neuro-Oncology Jg. 24 (2022) Nr. 9, S. 1609 - 1611Online Volltext: dx.doi.org/ (Open Access)
-
Medikamentöse Therapie der häufigsten HirnmetastasenIn: Die Onkologie Jg. 28 (2022) Nr. 5, S. 389 - 394Online Volltext: dx.doi.org/
-
Meningeosis neoplastica : Epidemiologie, Diagnostik und TherapieIn: Die Onkologie Jg. 28 (2022) Nr. 7, S. 395 - 404Online Volltext: dx.doi.org/
-
Correction to : Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high‑grade glioma in clinical practice (Journal of Neuro-Oncology, (2020), 148, 3, (489-500), 10.1007/s11060-020-03540-6)In: Journal of Neuro-Oncology Jg. 151 (2021) Nr. 2, S. 339Online Volltext: dx.doi.org/ (Open Access)
-
Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastomaIn: Clinical Neurology and Neurosurgery Jg. 200 (2021) 106348Online Volltext: dx.doi.org/
-
How about levetiracetam in glioblastoma? An institutional experience and meta‐analysisIn: Cancers Jg. 13 (2021) Nr. 15, 3770Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy : Lessons learned from the CeTeG/NOA-09 trialIn: International Journal of Cancer Jg. 148 (2021) Nr. 7, S. 1695 - 1707Online Volltext: dx.doi.org/ (Open Access)
-
Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practiceIn: Journal of Neuro-Oncology Jg. 148 (2020) Nr. 3, S. 489 - 500Online Volltext: dx.doi.org/ (Open Access)
-
Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastomaIn: Cancer Medicine Jg. 6 (2017) Nr. 1, S. 89 - 99Online Volltext: dx.doi.org/ (Open Access)
-
Bevacizumab Plus irinotecan versus temozolomide in newly diagnosed O⁶-methylguanine-DNA methyltransferase nonmethylated glioblastoma : The randomized GLARIUS trialIn: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. 14, S. 1611 - 1619Online Volltext: dx.doi.org/
-
Late Pseudoprogression in Glioblastoma : Diagnostic Value of Dynamic O-(2-[¹⁸ F]fluoroethyl)-L-Tyrosine PETIn: Clinical Cancer Research Jg. 22 (2016) Nr. 9, S. 2190 - 2196Online Volltext: dx.doi.org/
-
Phase II trial of temsirolimus for relapsed/refractory primary CNS lymphomaIn: Journal of Clinical Oncology (JCO) Jg. 34 (2016) Nr. 15, S. 1757 - 1763Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prognostic factors in recurrent glioblastoma patients treated with bevacizumabIn: Journal of Neuro-Oncology Jg. 129 (2016) Nr. 1, S. 93 - 100Online Volltext: dx.doi.org/
-
Sarcomeric lesions and remodeling proximal to intercalated disks in overload-induced cardiac hypertrophyIn: Experimental Cell Research Jg. 348 (2016) Nr. 1, S. 95 - 105Online Volltext: dx.doi.org/
-
The earlier the better? : Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastomaIn: Journal of Cancer Research and Clinical Oncology Jg. 142 (2016) Nr. 8, S. 1825 - 1829Online Volltext: dx.doi.org/
-
Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overloadIn: Journal of Negative Results in BioMedicine Jg. 15 (2016) Nr. 1, 9Online Volltext: dx.doi.org/ (Open Access)
-
¹⁸F-fluoroethyl-L-tyrosine positron emission tomography-guided diagnosis of a malignant intramedullary spinal cord tumorIn: Oncology Letters Jg. 12 (2016) Nr. 6, S. 4705 - 4707Online Volltext: dx.doi.org/ (Open Access)
-
¹⁸F–fluoroethyl–L–tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case reportIn: Oncology Letters Jg. 11 (2016) Nr. 3, S. 2195 - 2198Online Volltext: dx.doi.org/ (Open Access)
-
Tlr4 deficiency protects against cardiac pressure overload induced hyperinflammationIn: PLoS ONE Jg. 10 (2015) Nr. 11, e0142921Online Volltext: dx.doi.org/ (Open Access)
-
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant gliomaIn: Oncology Jg. 86 (2014) Nr. 5-6, S. 369 - 372Online Volltext: dx.doi.org/
-
FLAIR-Only progression in bevacizumab-treated relapsing glioblastoma does not predict short survivalIn: Oncology Jg. 85 (2013) Nr. 3, S. 191 - 195Online Volltext: dx.doi.org/
-
In vivo differentiation of human periodontal ligament cells leads to formation of dental hard tissueIn: Journal of Orofacial Orthopedics Jg. 74 (2013) Nr. 6, S. 494 - 505Online Volltext: dx.doi.org/
-
TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivoIn: Journal of Inflammation Jg. 10 (2013) Nr. 1, 33Online Volltext: dx.doi.org/ (Open Access)
-
Vemurafenib for leptomeningeal melanomatosisIn: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 11,Online Volltext: dx.doi.org/
-
Effect of intermittent PTH(1-34) on human periodontal ligament cells transplanted into immunocompromised miceIn: Tissue Engineering / Part A Jg. 18 (2012) Nr. 17-18, S. 1849 - 1856Online Volltext: dx.doi.org/ (Open Access)
-
AI Based Prediction of Clinical TTFields Response in Glioblastoma Patients (Retrospective Analysis)
29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,In: Neuro-Oncology Jg. 26 (2024) Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii112 - viii112Online Volltext: dx.doi.org/ -
Decoding glioblastoma survival : Unraveling the prognostic potential of olfactory function in a prospective observational study
29th Annual Meeting and Education Day of the Society-for-Neuro-Oncology (SNO): NOV 21-24, 2024; Houston, USA,In: Neuro-Oncology Jg. 26 (2024) Nr. Suppl. 8: Abstracts from the 2024 Society for Neuro-Oncology’s 29th Annual Meeting and Education Day, S. viii95 - viii95Online Volltext: dx.doi.org/ -
68Ga-NeoB PET for Glioma and Breast Cancer : First Results from a Prospective Observational Trial
Annual Congress of the European Association of Nuclear Medicine, 9-13 September 2023 Vienna, Austria,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 50 (2023) Nr. 1 supplement, S. S265Online Volltext: dx.doi.org/ (Open Access) -
Decoding glioblastoma survival : unraveling the prognostic potential of olfactory function in a prospective observational study
28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,In: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v92 - v92Online Volltext: dx.doi.org/ -
Fet pet sensitivity in primary brain tumors according to cns who 2021 : value and pitfalls in presurgical implementationIn: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v204 - v205Online Volltext: dx.doi.org/
-
Immunogenicity of an additional dose of covid-19 vaccine in fully vaccinated patients with glioma to evaluate new national vaccination guidelines : a prospective cohort studyIn: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v63 - v64Online Volltext: dx.doi.org/
-
Interim data on dual inhibition of post-radiogenic angio-vasculogenesis by olaptesed pegol (nox-a12) and bevacizumab in glioblastoma from the first expansion arm of the phase 1/2 gloria trial
28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,In: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v90 - v91Online Volltext: dx.doi.org/ -
Investigating safety and efficacy of ttfields prior and concomitant to radiotherapy in newly diagnosed glioblastoma : First results of the pricottf phase I/II trial
28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,In: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v91 - v92Online Volltext: dx.doi.org/ -
Predicting and targeting clonally expanding, tmz-resistant tumor cells in glioblastoma
28th Annual Scientific Meeting of the Society-for-Neuro-Oncology (SNO); NOV 15-19, 2023; Vancouver, Canada,In: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v110 - v110Online Volltext: dx.doi.org/ -
Safety and efcacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma : the PriCoTTF phase I/II trialIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 199 (2023) Nr. Suppl. 1, S. S32Online Volltext: dx.doi.org/ (Open Access)
-
Spatial remodeling of the immune tumor microenvironment after radiotherapy and CXCL12 inhibition in glioblastoma in the phase I/II GLORIA trial
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S395Online Volltext: dx.doi.org/ -
Temporal muscle thickness as a prognostic marker in a real-life cohort of newly diagnosed MGMT promoter methylated glioblastoma patients : a multicentric imaging analysisIn: Neuro-Oncology Jg. 25 (2023) Nr. Suppl. 5, S. v192 - v193Online Volltext: dx.doi.org/
-
PriCoTTF Trial : A Phase I//II Trial of TTFields Prior and Concomitant to Radiotherapy in newly diagnosed Glioblastoma
2021 Society for Neuro-Oncology’s 26th Annual Scientific Meeting and Education Day,In: Neuro-Oncology Jg. 23 (2021) Nr. Supplement_6, S. vi68 - vi68Online Volltext: dx.doi.org/ (Open Access)